Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders

Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders

VICTORIA, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to optimize drug delivery for applications with significant unmet need,…

Eupraxia Annual Meeting: Board Members Win Overwhelming 99% Shareholder Approval

Shareholders back all six board nominees with up to 99.99% support. Key proposals including incentive plan and auditor appointment receive strong approval. See full results.

Hemisphere Energy Announces Results from Annual General and Special Meeting of Shareholders

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - Hemisphere Energy Corporation (TSXV: HME) (OTCQX: HMENF) ('Hemisphere' or